UPDATED May 20, 2025
Explore the U.S. (NYSE and NASDAQ) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$747.01 | -1.1% | -7.0% | US$677.9b | US$955.01 | PE60.4x | E22.5% | 0.8% | ||
ABBV | US$184.85 | -0.5% | 13.5% | US$328.0b | US$210.57 | PE78.6x | E26.3% | 3.5% | ||
RPRX | US$33.09 | -3.4% | 21.8% | US$19.3b | US$41.52 | PE12.8x | E5.8% | 2.7% | ||
AMGN | US$275.01 | -0.3% | -12.7% | US$148.3b | US$314.00 | PE24.9x | E12.0% | 3.5% | ||
TEVA | US$16.78 | -1.4% | 1.1% | US$19.5b | US$22.88 | PS1.2x | E64.8% | 0% | ||
TEM | US$62.43 | -2.1% | n/a | US$11.0b | US$65.50 | PS13.5x | E72.1% | n/a | ||
ZTS | US$163.65 | -0.2% | -5.3% | US$73.0b | US$194.43 | PE28.9x | E7.4% | 1.2% | ||
WST | US$215.43 | -0.8% | -36.1% | US$15.6b | US$281.92 | PE33.1x | E10.6% | 0.4% | ||
STVN | US$24.32 | -1.9% | 26.3% | US$6.8b | US$27.31 | PE46.9x | E18.9% | 0.2% | ||
EXEL | US$44.36 | -0.7% | 111.0% | US$12.2b | US$40.78 | PE18.8x | E19.0% | n/a | ||
ALVO | US$9.78 | -2.9% | -29.8% | US$3.0b | US$18.00 | PE30.6x | E49.4% | n/a | ||
RVTY | US$93.58 | -0.8% | -17.4% | US$11.1b | US$124.84 | PE37.3x | E20.0% | 0.3% | ||
AVXL | US$7.53 | -10.8% | 73.1% | US$720.5m | US$34.33 | PB6.4x | E59.1% | n/a | ||
ELAN | US$13.08 | -1.1% | -21.7% | US$6.6b | US$14.27 | PE17.4x | E-0.7% | n/a | ||
PBH | US$87.56 | -1.6% | 34.6% | US$4.4b | US$88.50 | PE20.2x | E4.4% | n/a | ||
TMO | US$413.75 | -0.04% | -29.9% | US$156.3b | US$570.17 | PE24x | E10.1% | 0.4% | ||
OGN | US$8.76 | -2.7% | -59.9% | US$2.3b | US$16.17 | PE3x | S0.8% | 0.9% | ||
ZYBT | US$7.75 | -14.2% | n/a | US$367.3m | n/a | PE130.7x | n/a | n/a | ||
ACAD | US$21.69 | -1.4% | 42.0% | US$3.7b | US$25.89 | PE15.9x | E22.8% | n/a | ||
ALMS | US$4.88 | -18.0% | n/a | US$265.5m | US$21.25 | PS15.3x | E2.2% | n/a | ||
NUVB | US$2.17 | -5.7% | -36.2% | US$782.6m | US$7.83 | PS67.4x | E56.9% | n/a | ||
BIO | US$247.05 | -0.6% | -14.6% | US$6.8b | US$318.67 | PS2.6x | E64.1% | n/a | ||
ZLAB | US$32.63 | -1.1% | 63.1% | US$3.6b | US$54.59 | PS8.5x | E64.1% | n/a | ||
MNKD | US$4.36 | -2.6% | -8.1% | US$1.4b | US$10.29 | PE44x | E29.5% | n/a |